Amgen Inc (AMGN)
283.61
-12.32
(-4.16%)
USD |
NASDAQ |
Nov 15, 16:00
283.55
-0.06
(-0.02%)
After-Hours: 20:00
Amgen Research and Development Expense (TTM): 5.774B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.774B |
| June 30, 2024 | 5.403B |
| March 31, 2024 | 5.069B |
| December 31, 2023 | 4.784B |
| September 30, 2023 | 4.574B |
| June 30, 2023 | 4.607B |
| March 31, 2023 | 4.533B |
| December 31, 2022 | 4.434B |
| September 30, 2022 | 4.458B |
| June 30, 2022 | 4.768B |
| March 31, 2022 | 4.811B |
| December 31, 2021 | 4.819B |
| September 30, 2021 | 4.70B |
| June 30, 2021 | 4.34B |
| March 31, 2021 | 4.222B |
| December 31, 2020 | 4.207B |
| September 30, 2020 | 4.29B |
| June 30, 2020 | 4.229B |
| March 31, 2020 | 4.189B |
| December 31, 2019 | 4.116B |
| September 30, 2019 | 3.986B |
| June 30, 2019 | 3.911B |
| March 31, 2019 | 3.856B |
| December 31, 2018 | 3.737B |
| September 30, 2018 | 3.598B |
| Date | Value |
|---|---|
| June 30, 2018 | 3.549B |
| March 31, 2018 | 3.553B |
| December 31, 2017 | 3.562B |
| September 30, 2017 | 3.597B |
| June 30, 2017 | 3.71B |
| March 31, 2017 | 3.737B |
| December 31, 2016 | 3.84B |
| September 30, 2016 | 3.855B |
| June 30, 2016 | 3.984B |
| March 31, 2016 | 4.048B |
| December 31, 2015 | 4.07B |
| September 30, 2015 | 4.211B |
| June 30, 2015 | 4.11B |
| March 31, 2015 | 4.164B |
| December 31, 2014 | 4.297B |
| September 30, 2014 | 4.312B |
| June 30, 2014 | 4.283B |
| March 31, 2014 | 4.232B |
| December 31, 2013 | 4.083B |
| September 30, 2013 | 3.772B |
| June 30, 2013 | 3.663B |
| March 31, 2013 | 3.522B |
| December 31, 2012 | 3.38B |
| September 30, 2012 | 3.293B |
| June 30, 2012 | 3.174B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
4.116B
Minimum
Dec 2019
5.774B
Maximum
Sep 2024
4.616B
Average
4.554B
Median
Research and Development Expense (TTM) Benchmarks
| Johnson & Johnson | 16.41B |
| Eli Lilly and Co | 10.53B |
| Merck & Co Inc | 22.98B |
| Regeneron Pharmaceuticals Inc | 4.897B |
| Viking Therapeutics Inc | 91.16M |